Validity and Reliability of the Dual-task Questionnaire

• Sponsor: Gazi University (Other)
• Overall Status: Completed
• CT.gov ID: NCT05188937
• Collaborator: (none)
• Enrollment: 50
• Location: 1
• Arm: 1
• Actual Duration (Months): 15
• Patients Per Site Per Month: 3.3

Study Details

Study Description

Brief Summary

It is important to increase the independence of Multiple Sclerosis (MS) patients in activities of daily living. Almost all activities of daily living require managing many activities at the same time. For example, walking or standing while talking on the phone. There is a need for easily applicable, reliable and valid scales to evaluate dual-task performance in MS patients. Therefore, the aim of this study is to establish the Turkish cultural adaptation, validity and reliability of the Dual-Task Questionnaire scale in MS patients. This study included a total of 50 patients with MS [age (18-65) years]. Dual-task Questionnaire (DTQ), Timed Up and Go test (TUG) with dual-task and Nine Hole Peg test (9-HPT) with dual-task were applied to the patients. The second evaluation (retest) was carried out by the same physiotherapist one week following the first evaluation (test) in order to measure test-retest reliability.

Condition or Disease	Intervention/Treatment	Phase
Multiple Sclerosis	Procedure: validity and reliability study	N/A

Detailed Description

This study included patients with MS between 0-5,5 score according to the Extended Disability Status Scale (EDSS). DTQ was used to assess the frequency of difficulties associated with daily tasks involving the dual-task. Additionally TUG with dual-task and 9-HPT with dual-task were applied to the patients. An experienced physiotherapist applied all these tests. In order to measure test-retest reliability, a retest was carried out by the same physiotherapist one week following the first evaluation. The construct validity of DTQ was tested by Pearson's correlation coefficient.

Study Design

• Study Type: Interventional
• Actual Enrollment: 50 participants
• Allocation: N/A
• Intervention Model: Single Group Assignment
• Intervention Model Description: Cross-SectionalCross-Sectional
• Masking: None (Open Label)
• Primary Purpose: Prevention
• Official Title: Validity and Reliability of the Dual-task Questionnaire in Multiple Sclerosis Patients
• Actual Study Start Date: Feb 1, 2021
• Actual Primary Completion Date: Oct 1, 2021
• Actual Study Completion Date: May 5, 2022

Arms and Interventions

Arm	Intervention/Treatment
Experimental: validity and reliability of Dual-task Questionnaire This study was conducted as "test-retest" design and the psychometric properties of Dual-task Questionnaire were examined in patients with MS.	Procedure: validity and reliability study; Validity and reliability assessment of the Dual-task Questionnaire

Outcome Measures

Primary Outcome Measures

1. Validity and reliability of Dual-Task Questionnaire in patients with MS [one week]

   Validity and reliability

Eligibility Criteria

Criteria

• Ages Eligible for Study: 18 Years to 65 Years
• Sexes Eligible for Study: All
• Accepts Healthy Volunteers: No

Inclusion Criteria:

• Clinical diagnosis of Multiple Sclerosis

• Must be able to ambulatory status (Expanded Disability Status Scale score ≤ 6 )

• No relapse in the last 3 mounts

Exclusion Criteria:

• Orthopedic problems

• Visual, perception, and hearing problems

Contacts and Locations

Locations

	Site	City	State	Country	Postal Code
1	Gazi University, Faculty of Health Sciences, Department of Physiotherapy and Rehabilitation	Ankara		Turkey

Sponsors and Collaborators

• Gazi University

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

• Evans JJ, Greenfield E, Wilson BA, Bateman A. Walking and talking therapy: improving cognitive-motor dual-tasking in neurological illness. J Int Neuropsychol Soc. 2009 Jan;15(1):112-20. doi: 10.1017/S1355617708090152.

• Responsible Party: Sefa Eldemir, Research Assistant, Gazi University
• ClinicalTrials.gov Identifier: NCT05188937
• Other Study ID Numbers: 1- MS-DTQ-VALİDİTY
• First Posted: Jan 12, 2022
• Last Update Posted: May 27, 2022
• Last Verified: May 1, 2022

• Studies a U.S. FDA-regulated Drug Product: No
• Studies a U.S. FDA-regulated Device Product: No
• Keywords provided by Sefa Eldemir, Research Assistant, Gazi University: Multiple Sclerosis; Dual-Task; Validity; Reliability
• Additional relevant MeSH terms: Multiple Sclerosis; Sclerosis

Study Results

No Results Posted as of May 27, 2022